Location History:
- Hong Kong, CN (2014)
- Shatin, CN (2014)
Company Filing History:
Years Active: 2014
Title: Innovations in Gastric Cancer Diagnosis and Treatment by Xiaoxing Li
Introduction
Xiaoxing Li is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of medical diagnostics, particularly in the area of gastric cancer. With a total of 2 patents, his work focuses on innovative methods for diagnosing and treating this serious condition.
Latest Patents
Xiaoxing Li's latest patents include groundbreaking inventions aimed at improving gastric cancer diagnosis and treatment. One of his notable patents is a method for diagnosing and determining the prognosis of gastric cancer by detecting suppressed expression of the BCL6B gene. This suppression is often linked to elevated methylation levels in the genomic sequence of this gene. The invention also includes a kit and device designed for this diagnostic method. Additionally, he has developed a method for treating gastric cancer by increasing the expression or activity of the BCL6B gene.
Another significant patent involves the use of the PAX5 gene as a marker for diagnosing and prognosing gastric cancer. This invention outlines methods for detecting gastric cancer and inhibiting its growth, providing valuable tools for healthcare professionals.
Career Highlights
Xiaoxing Li is affiliated with The Chinese University of Hong Kong, where he conducts research and develops innovative solutions for medical challenges. His work has garnered attention for its potential impact on patient outcomes in gastric cancer treatment.
Collaborations
Xiaoxing Li collaborates with esteemed colleagues, including Jun Yu and Joseph Jao Yiu Sung. Their combined expertise enhances the research and development of effective diagnostic and therapeutic methods.
Conclusion
Xiaoxing Li's contributions to the field of gastric cancer research exemplify the importance of innovation in medical science. His patents not only advance diagnostic techniques but also offer new avenues for treatment, ultimately aiming to improve patient care and outcomes.